Glucotrack announces poster presentation on continuous blood glucose monitor survey data at the association of diabetes care and education specialists (adces) 2024 annual conference

Market research data shows interest in additional glucose monitoring options for people with diabetes who use insulin rutherford, nj, aug. 05, 2024 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that an emerging science industry poster will be presented at the association of diabetes care and education specialists (adces) 2024 annual conference to be held august 9-12, 2024 in new orleans, la. the glucotrack poster will present market research data on the acceptance of the company's continuous blood glucose monitor (cbgm) concept among people with type 1 and type 2 diabetes.
GCTK Ratings Summary
GCTK Quant Ranking